Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe Adult AD Patients
Clinical trial NCT06465732 · UNKNOWN
Trial details
- NCT number
- NCT06465732
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2025-11-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.